All Stories

  1. Post hoc analyses of SHIFT and PARADIGM-HF highlight the importance of chronic Chagas' cardiomyopathy Comment on: “Safety profile and efficacy of ivabradine in heart failure due to Chagas heart disease: a post hoc analysis of the SHIFT trial” by Bocchi et

    Article • ESC Heart Failure, October 2018, Wiley

    Professor Karl Swedberg

  2. Effect of sacubitril/valsartan on recurrent events in the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF)

    Article • European Journal of Heart Failure, February 2018, Wiley

    Professor Karl Swedberg

  3. Lessons for the monitoring of safety in clinical trials

    Article • European Journal of Heart Failure, November 2017, Wiley

    Professor Karl Swedberg

  4. Can beta-blockers be used safely in non-cardiac surgery? Important lessons to be learned

    Article • European Heart Journal, June 2017, Oxford University Press (OUP)

    Professor Karl Swedberg

  5. Treatment of diabetes and heart failure: joint forces

    Article • European Heart Journal, February 2016, European Society of Cardiology

    Professor Karl Swedberg

  6. Disease‐specific health status as a predictor of mortality

    Article • European Journal of Heart Failure, July 2014, Wiley

    Professor Karl Swedberg